Cronos (CRON) enters into a multi-year private label marijuana concentrate agreement

: CRON | Cronos Group Inc. - Common Share News, Ratings, and Charts

CRON – MediPharm will supply Cronos with about $30 million of high-quality private label cannabis concentrate over the next 18 months.

Cronos (CRON – Get Report) shares were rising more than 3% in trading Tuesday to $14.77 after the company announced that it has entered into a multi-year private label cannabis concentrate supply agreement MediPharm Labs (MEDIF)

MediPharm will supply Cronos with about $30 million of high-quality private label cannabis concentrate over the next 18 months. The deal has a provision for that total to increase to $60 million over 24 months.

Cronos will also use MediPharm Labs’ extraction facility in Ontario to fulfill certain processing needs under a separate agreement.

“As the industry develops and matures, we see opportunity to work with companies like MediPharm Labs that provide specialized, high-quality services and inputs for our products,” said Mike Gorenstein, CEO of Cronos Group. “Along with our internal capabilities, we are pleased to be working with MediPharm Labs to bring great products to consumers in anticipation of the derivative market launching in Canada this fall.”

Cronos’ Peace Naturals subsidiary will be developing the new products spawned from the agreement.

“With the continued evolution of the Canadian cannabis industry, we are excited to partner with Cronos Group in their journey to launch new products and secure MediPharm Labs’ high-quality private label supply of concentrates,” said Patrick McCutcheon, CEO of MediPharm Labs. “We look forward to supporting the team at Cronos Group with our specialized extraction capabilities and expertise to address a rapidly expanding cannabis market and growing consumer demand.”

Cronos was trading at $14.70.


Cronos Group Inc. shares were trading at $15.36 per share on Tuesday afternoon, up $1.11 (+7.79%). Year-to-date, Cronos Group Inc. - Common Share (CRON - Get Rating) has gained 47.83%, versus a 14.41% rise in the benchmark S&P 500 index during the same period.

Cronos Group Inc. - Common Share (CRON - Get Rating) currently has a StockNews.com POWR Rating of D (Sell), and is ranked #14 of 26 stocks in the Agriculture category.


This article is brought to you courtesy of TheStreet.

 

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Top Stories on StockNews.com

NYSE: GPL | Great Panther Mining Limited Ordinary Shares (Canada) News, Ratings, and Charts

Best & Worst Performing Stock Industries for July 18, 2019

Led by ticker GPL, "Miners - Silver" was our best performing stock industry of the day, with a 5.96% gain.
NASDAQ: TEDU | Tarena International, Inc. News, Ratings, and Charts

Best & Worst Performing Small Cap Stocks for July 18, 2019

TEDU leads the way today as the best performing small cap stock, closing up 49.59%.
NYSE: GFI | Gold Fields Limited American Depositary Shares News, Ratings, and Charts

Best & Worst Performing Mid Cap Stocks for July 18, 2019

GFI leads the way today as the best performing mid cap stock, closing up 8.02%.
NYSE: PM | Philip Morris International Inc Common Stock News, Ratings, and Charts

Best & Worst Performing Large Cap Stocks for July 18, 2019

PM leads the way today as the best performing large cap stock, closing up 8.22%.
NYSE: PM | Philip Morris International Inc Common Stock News, Ratings, and Charts

Best & Worst Performing Mega Cap Stocks for July 18, 2019

PM leads the way today as the best performing mega cap stock, closing up 8.22%.

Read More Stories


More Cronos Group Inc. - Common Share (CRON) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CRON News
Page generated in 1.1353 seconds.